Managing financial integrity in a complex, milestone-driven operating model.
Samir Shah
Advertisement
President, Strategic Solutions, ICON
Articles by Samir Shah
A data-fueled framework for sponsors and CROs in navigating this shifting terrain.
Can full-service outsourcing to CROs by large biopharma companies sustainably prosecute a clinical development portfolio?
Differentiating FSO and FSP approaches can better align definitions of models for CROs and sponsors.
Advertisement
Latest Updated Articles
Anticipating Near-Term Structural Change in the Outsourcing LandscapeDecember 22nd 2023
The Strategic Emergence of Site Networks in Clinical ResearchOctober 14th 2024
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
2026 DIA Global Annual Meeting: What Drives Sponsors to Mixed Outsourcing Models and What the Transition Looks Like
2
2026 DIA Global Annual Meeting: Why Protocol Digitization Has Been So Hard to Automate—Until Now
3
Tapping the Global Potential of China’s Biotech Surge
4
2026 DIA Global Annual Meeting: How DCT Models Are Changing Recruitment and Retention for Sponsors
5